You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SBIR PHASE 1: SCALABLE DIGITAL DELIVERY OF EVIDENCE-BASED TRAINING FOR FAMILY TO MAXIMIZE TREATMENT ADMISSION RATES OF OPIOID USE DISORDER IN LOVED ON

    SBC: WE THE VILLAGE, INC.            Topic: 166

    To determine the feasibility of replicating Community Reinforcement And Family Training (CRAFT) efficacy when delivering the protocol via scalable digital coaching methods

    SBIR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health
  2. Interactive e-learning to promote successful postsecondary employment outcomes for students with intellectual disabilities

    SBC: 3-C Institute for Social Development, Inc.            Topic: N/A

    Employment is essential for helping individuals with intellectual disabilities achieve independence, financial security, and self-sufficiency to be active members in the community as well as foster a higher quality of life more generally. However, only 25% of individuals with intellectual disabilities are employed two years after high school. Utilizing 3C’s proprietary dynamic e-learning platfor ...

    SBIR Phase I 2014 Department of Education
  3. Continuous fermentation bioprocess resolving food waste issues from Greek yogurt production

    SBC: CAPRO-X INC            Topic: 19NCER5B

    Capro-X is a sustainable biotechnology company focused on commercializing a patent-pending fermentation process, called the WheyAway system. The WheyAway introduces a solution for the dairy industry to upgrade processing waste streams from cheese and yogurt production into sustainable biochemicals, which we call bio-oil. Capro-X is currently focused on solving a key waste problem experienced by th ...

    SBIR Phase I 2020 Environmental Protection Agency
  4. In Situ Remediation Technology (InSRT) for Remediation of PFAS Contaminated Groundwater

    SBC: REMWELL LLC            Topic: 19NCER1C

    Per- and Polyfluoroalkyl substances (PFAS) are persistent chemicals that have been introduced to the environment through manufacturing, use, and disposal of products containing PFAS. Some PFAS have been phased out of production; however, their legacy persists through widespread contamination of air, water, soil, and biota. The U.S. EPA has issued a lifetime drinking water Health Advisory Level (HA ...

    SBIR Phase I 2020 Environmental Protection Agency
  5. Electrodialytic nutrient recovery from wastewater

    SBC: Triangle Environmental Health Initiative LLC            Topic: 19NCER1G

    Nutrient pollution contributes to global water quality issues in the form of eutrophication, which leads to algal blooms and dead zones due to oxygen depletion, as well as public health issues such as methemoglobinemia. A major source of that nutrient pollution is inadequately treated sewage, in particular, from non-sewered sanitation systems (NSSS) which are not designed to remove nutrients befor ...

    SBIR Phase I 2020 Environmental Protection Agency
  6. A biomarker of aging as a predictor of kidney transplant function

    SBC: HEALTHSPAN DIAGNOSTICS, LLC            Topic: NIA

    ABSTRACT The number of kidney transplant candidates on the waiting list continues to increase each year, while the number of kidney donations remains stagnant. The enduring donor shortage compels clinicians to use kidneys from marginal donors, referred toas expanded criteria donors (ECD). ECD kidneys, obtained primarily from older donors, have a higher risk of delayed graft function and graft loss ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Biosensor Assays for Diagnosis of Chronic HCV Infection

    SBC: ALDERON BIOSCIENCES, INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): This Phase I SBIR application is submitted in response to the call by DHHS for new tests for qualitative measurement of HCV RNA for diagnosis of chronic HCV infection in patients. The need is for HCV RNA assays that areas reliable but less expensive and resource-demanding than current molecular assays. The new test proposed for research and development consists ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. Innovative Positive Juvenile Justice Tools for Youth Courts

    SBC: National Health Promotion Associates, Inc.            Topic: NIDA

    ABSTRACT Adolescents in underserved, urban communities are disproportionately involved in the juvenile justice system. Youth involvement in the court system is a serious public health concern. In recent years, juvenile justice professionals have begun to supplement traditional efforts aimed at discipline and punishment with an asset- based perspective referred to as positive youth justice (PYJ). ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. A Generic Cross-Platform Perception API for Unmanned Vehicles

    SBC: Honeybee Robotics, Ltd.            Topic: OSD13HS4

    ABSTRACT: Autonomous vehicles lack a standardized mechanism for seamless cross-platform sharing of testing frameworks and evaluations of basic tasks. The ability to execute common tests on various hardware platforms is essential in order to be able to e

    SBIR Phase I 2014 Department of DefenseDefense Threat Reduction Agency
  10. Enhanced Optical Module to Enable Polarized 129Xe MRI Use in Clinical Trials

    SBC: POLAREAN, INC.            Topic: NHLBI

    DESCRIPTION (provided by applicant): There are now 50+ new drugs in Phase II-III development to treat COPD - a disease affecting 13 million Americans, costing 49B and killing 120,000 each year. However, a major limitation in evaluating therapies for thesechronic diseases is the lack of a sufficiently sensitive and non-invasive method for drug developers to see efficacy on timescales of days rathe ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government